Dr. Christopher Burns
Honorary
Chemistry
67 Scholarly works
0 Projects
HIGHLIGHTS
2020
Journal article
A constricted opening in Kir channels does not impede potassium conduction
DOI: 10.1038/s41467-020-16842-02020
Journal article
TBK1 and IKK epsilon Act Redundantly to Mediate STING-Induced NF-kappa B Responses in Myeloid Cells
DOI: 10.1016/j.celrep.2020.03.0562020
Journal article
HBO1 is required for the maintenance of leukaemia stem cells
DOI: 10.1038/s41586-019-1835-62019
Journal article
Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis
DOI: 10.1002/art.406702018
Journal article
Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer.
DOI: 10.18632/oncotarget.246152017
Journal article
Design, Synthesis, and Biological Activity of 1,2,3-Triazolobenzodiazepine BET Bromodomain Inhibitors
DOI: 10.1021/acsmedchemlett.7b003892017
Journal article
Defining a therapeutic window for kinase inhibitors in leukemia to avoid neutropenia
DOI: 10.18632/oncotarget.19678
RECENT SCHOLARLY WORKS
2017
Journal article
Cisplatin Increases Sensitivity to FGFR Inhibition in Patient-Derived Xenograft Models of Lung Squamous Cell Carcinoma
DOI: 10.1158/1535-7163.MCT-17-01742017
Journal article
Repurposed JAK1/JAK2 Inhibitor Reverses Established Autoimmune Insulitis in NOD Mice
DOI: 10.2337/db16-12502016
Journal article
Biochemical and Structural Insights into Doublecortin-like Kinase Domain 1
DOI: 10.1016/j.str.2016.07.008